Notice of Refund | Jun 5, 2017 | PAPER | BOARD |
PETITIONER'S REQUEST FOR REFUND OF POST-INSTITUTION FEES | May 25, 2017 | PAPER | PETITIONER |
Termination Decision Document | Apr 11, 2017 | PAPER | BOARD |
Petitioner's Unopposed Motion to Dismiss Petitions Without Prejudice | Apr 7, 2017 | PAPER | PETITIONER |
Order Conduct of the Proceeding | Apr 7, 2017 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Mar 23, 2017 | PAPER | PETITIONER |
Patent Owner's Second Updated Mandatory Notices | Mar 17, 2017 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Feb 27, 2017 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Feb 24, 2017 | PAPER | BOARD |
Patent Owner's Power of Attorney | Feb 21, 2017 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Feb 21, 2017 | PAPER | PATENT OWNER |
PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. 311-319 AND 37 C.F.R. 42 | Jan 31, 2017 | PAPER | PETITIONER |
U.S. Patent No. 9,085,619 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2016/0319011 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. App. 60/690,582 | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Jan. 2008) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Declaration of David D. Sherry, M.D. | Jan 31, 2017 | EXHIBIT | PETITIONER |
Petitioner's Signed Power of Attorney | Jan 31, 2017 | PAPER | PETITIONER |
Declaration of Klaus-Peter Radtke, Ph.D. | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Jan. 2003) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Adalimumab Product Approval Information | Jan 31, 2017 | EXHIBIT | PETITIONER |
AbbVie Biotechnology Ltd., Annex A - The Humira Story | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2003/0206898 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Parslow 1997 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Jefferis et al. 1995 | Jan 31, 2017 | EXHIBIT | PETITIONER |
McDonnell 2015 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Christensen 1966 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Gokarn et al. 2006 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Butler & Hamilton 1991 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Van Slyke 1922 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Gelfand 2006 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Fransson & Espander-Jansson 1996 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2003/0138417 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Laursen et al. 2006 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Frenken et al. 1993 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Nozaki & Tanford 1967 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Olthuis et al. 1994 | Jan 31, 2017 | EXHIBIT | PETITIONER |
GAMIMUNE Label (Oct. 2005) | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 14/506,576 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 13/774,735 - PART 1 of 2 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 13/774,735 - PART 2 of 2 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Physicians Desk Reference (56th ed. 2002) | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 12/325,049 - PART 3 of 6 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 12/325,049 - PART 4 of 6 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 12/325,049 - PART 1 of 6 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 12/325,049 - PART 2 of 6 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 12/325,049 - PART 6 of 6 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 61/004,992 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Stoner et al. 2004 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Fraunhofer Substantive Motion 3, Patent Interference No. 106,057 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Gebhart 2001 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Carnahan et al. 2003 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2012/0028877 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,090,382, Salfeld et al. | Jan 31, 2017 | EXHIBIT | PETITIONER |
Schwartzman & Morgan 2004 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Development Pharmaceutics for Biotechnological and Biological Products (Oct. 21, 1999) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Patent Owner's Preliminary Response, IPR2016-01018, Paper No. 9 | Jan 31, 2017 | EXHIBIT | PETITIONER |
A Bioworld Special Report: Biosimilars: U.S. Market Opportunities and Critical Strategies 2016 | Jan 31, 2017 | EXHIBIT | PETITIONER |
WO 1997/029131, Salfeld et al. | Jan 31, 2017 | EXHIBIT | PETITIONER |
Schwartz 2003 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2004/0033535 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Press Release (Jan. 23, 2003) | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2013/0273066 | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2008/0311078 | Jan 31, 2017 | EXHIBIT | PETITIONER |
WO 2006/138181, Gokarn et al. | Jan 31, 2017 | EXHIBIT | PETITIONER |
Gottlieb 2005 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Granolleras et al. 1991 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Clinical Pharmacology and Biopharmaceutics Review(s), Application No. 125057/0, in Approval Package for Humira (Approved Dec. 31, 2002) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Nov. 2015) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Oct. 2016) | Jan 31, 2017 | EXHIBIT | PETITIONER |
SYNAGIS Label (July 2004) | Jan 31, 2017 | EXHIBIT | PETITIONER |
CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) | Jan 31, 2017 | EXHIBIT | PETITIONER |
GAMMAGARD LIQUID Label (April 2005) | Jan 31, 2017 | EXHIBIT | PETITIONER |
OCTAGAM Label (Mar. 2004) | Jan 31, 2017 | EXHIBIT | PETITIONER |
GAMUNEX Label (Nov. 2005) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Privigen Label (Oct. 2016) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Vectibix Label (Sept. 2006) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Akers et al. 2002 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Hanna (Mar. 10, 2003) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Handbook of Pharmaceutical Excipients (5th ed. 2006) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Injection Tips (Archived Mar. 17, 2005) | Jan 31, 2017 | EXHIBIT | PETITIONER |
van de Putte, et al. (September 1998) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Oct. 2005) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Meadows & Hollowell (2008) | Jan 31, 2017 | EXHIBIT | PETITIONER |
ENBREL Label (Nov. 1998) | Jan 31, 2017 | EXHIBIT | PETITIONER |
REMICADE Label (Aug. 1998) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Vivaglobin Label (Jan. 2006) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Flebogamma Label (Jan. 2004) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HepaGam B Summary Basis for Approval (Jan. 2006) | Jan 31, 2017 | EXHIBIT | PETITIONER |
AVASTIN Label (Feb. 2004) | Jan 31, 2017 | EXHIBIT | PETITIONER |
TYSABRI Label (Nov. 2004) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Campath Label (Aug. 2006) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Cleland & Langer 1994 | Jan 31, 2017 | EXHIBIT | PETITIONER |
Note for Guidance on Development Pharmaceutics (Jan. 28, 1998) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Dean, Lange's Handbook of Chemistry (9th ed. 1999) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Feb. 2008) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Feb. 2007) | Jan 31, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Nov. 2006) | Jan 31, 2017 | EXHIBIT | PETITIONER |
ENBREL Label (Sept. 2002) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Tsourounis (June 2005) | Jan 31, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,696,056, Cheung et al. | Jan 31, 2017 | EXHIBIT | PETITIONER |
Summary Review for Regulatory Action, Sarah Yim, Division of Pulmonary, Allergy, and Rheumatology Products (U.S. FDA), of Humira (2015) | Jan 31, 2017 | EXHIBIT | PETITIONER |
Nash (2016) | Jan 31, 2017 | EXHIBIT | PETITIONER |